Home › Sjogren's Syndrome › Illinois › Cicero
Sjogren's Syndrome clinical trials in Cicero, IL
4 studies for Sjogren's Syndrome are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- Willow Rheumatology Wellness, Willowbrook · 11 mi away
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
RecruitingPhase 2
- Willow Rheumatology Wellness, Willowbrook · 11 mi away
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Willow Rheumatology & Wellness, Willowbrook · 11 mi away
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Willowbrook, Willowbrook · 11 mi away
About Sjogren's Syndrome
Sjogren's Syndrome is an autoimmune disease that causes dryness of the mouth, eyes and other parts of the body. Learn how to relieve the symptoms.
More about Sjogren's Syndrome on MedlinePlus
Sjogren's Syndrome trials in other cities
- Houston, TX6 studies
- Boston, MA5 studies
- Washington, DC5 studies
- Charlotte, NC4 studies
- Tampa, FL4 studies
- Arlington, TX4 studies
- Warren, MI3 studies
- Clearwater, FL3 studies
- Kansas City, MO3 studies
- Tucson, AZ3 studies
- Cypress, TX3 studies
- Orlando, FL3 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Breast Cancer11 studies
- Acute Myeloid Leukemia11 studies
- Colorectal Cancer10 studies
- Bladder Cancer8 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Metastatic Cancer7 studies
- Multiple Myeloma6 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.